OncoGenex Stays in Prostate Cancer Fray, After J&J, MedivationLuke Timmerman1/27/12Prostate cancer was once a backwater for innovation, but suddenly it’s become one of the most competitive battlegrounds in all of biotech.
OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation …
Sursa:
OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation …